等待開盤 07-31 09:30:00 美东时间
+0.032
+4.40%
The peer-reviewed evaluation analyzed the efficacy, pharmacokinetics, and safety data obtained from over 50 studies using low-dose cannabidiol (CBD) commonly found in over-the-counter products — and exposes critical limitations and risks of these non-prescription CBD preparations at the doses admini...
07-22 20:41
Artelo Biosciences' ART27.13 shows promise in treating neuropathic pain in cancer patients, particularly those experiencing weight loss due to cancer. Nonclinical studies demonstrate its ability to reduce pain-related behaviors and improve body weight and activity levels. Interim results from the CAReS Phase 2 trial highlight its potential broader utility in cancer supportive care, addressing both anorexia cachexia syndrome and chemotherapy-induc...
07-13 13:02
Artelo Biosciences, Inc. (NASDAQ:ARTL) ("Artelo" or the "Company"), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatological, or neurological conditions, announces that Myles Osborn, Lead Medicina...
06-10 19:40
-SEC Filing
05-27 04:55
Gainers: PHGE +97.3%, ARTL +74.8%, QTEX +52.4%, MNTX +34.4%, HLIT +28.3%, WOK +25%, CPSH +24.7%, CODX +22.7%, MDAI +22%. Losers: AKTX -25.2%, RYOJ -18.6%, DEVS -18.6%, AKAN -17%, ADTX -16.3%, LFS -15.6%
05-26 18:00
Wheeler房产投资信托涨-15.03%;康诺斯全球涨-11.28%;rYojbaba Co., Ltd.涨-11.00%
05-26 08:05